Xiaofei Su
Nanjing Medical University
59 Papers
140 Citations
Xiaofei Su is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Glycemic & Medicine. The author has an hindex of 10, co-authored 42 publications.
Chat about Author
Papers
Effects of GLP-1 Receptor Agonists on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus: A 52-Week Clinical Study.
TL;DR: In this paper, the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and insulin on bone mineral density (BMD) in T2DM patients were investigated.
Association of lower body mass index with increased glycemic variability in patients with newly diagnosed type 2 diabetes: a cross-sectional study in China.
Jian Wang,Rengna Yan,Juan Wen,Xiaocen Kong,Huiqin Li,Peihua Zhou,Hong-hong Zhu,Xiaofei Su,Jianhua Ma +8 more
TL;DR: Lower BMI was associated with increased glycemic variability, characterized by elevated PPGEs, in newly diagnosed Chinese type 2 diabetic patients, and on multiple linear regression analyses, BMI and Insulin Secretion Sensitivity Index-2 were two independent predictors of gly glucose variability.
Influence of Dapagliflozin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
TL;DR: The ability of dapagliflozin to improve glycemic variations and associate with reduction of oxidative stress in patients with T2DM is shown, which may benefit the cardiovascular system.
Twenty Minute Moderate-Intensity Post-Dinner Exercise Reduces the Postprandial Glucose Response in Chinese Patients with Type 2 Diabetes.
TL;DR: A short session of moderate-intensity post-dinner exercise can improve postprandial hyperglycemia and glycemic excursions in Chinese patients with type 2 diabetes, with no potential hypoglycemia risk at a later period.
The prostaglandin H2 analog U-46619 improves the differentiation efficiency of human induced pluripotent stem cells into endothelial cells by activating both p38MAPK and ERK1/2 signaling pathways
Liping Su,Xiaocen Kong,Sze-Yun Lim,Szejie Loo,Shihua Tan,Kian Keong Poh,James R. Dutton,Colin L. Stewart,Stuart A. Cook,Stuart A. Cook,Stuart A. Cook,Xiaofei Su,Jianhua Ma,Jianyi Zhang,Lei Ye +14 more
TL;DR: It is demonstrated that activating both p38MAPK and ERK1/2 signaling pathways with U-46619 improves the efficiency of arteriovenous hiPSC-EC differentiation and produces cells with greater proliferative capacity.
24